Clinical Trial Update: Study to Evaluate the Efficacy of MONotherapy of TiviCAY® Versus a Triple Therapy in HIV-1-infected Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating monotherapy with TiviCAY versus a triple therapy in HIV-1-infected patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: Centre Hospitalier Régional d'Orléans | Conditions: HIV | Phase 3 | Status: TERMINATED